SEC24D: A Potential Drug Target and Biomarker for Protein Transport

Target Name: SEC24D

NCBI ID: G9871

SEC24D

SEC24D: A Potential Drug Target and Biomarker for Protein Transport

Introduction

Protein transport proteins, such as Sec24D (isoform 1), play a crucial role in the efficient delivery of proteins from the cytoplasm to various cellular structures, including the endoplasmic reticulum (ER), pericellular structures, and the cell surface. SEC24D, an essential protein of the heat shock protein (HSP) family, is known to mediate protein transport in various cell types, including bacteria, yeast, and mammalian cells. Its function in protein transport is highly conserved across different organisms, making it an attractive drug target and biomarker for various diseases.

SEC24D: Structure and Function

The Sec24D protein is a 21-kDa protein that contains a unique N-terminal region, a long N-terminus, and a C-terminal region with a conserved hydrophobic structure. It has a molecular weight of approximately 26 kDa and a calculated pI of 6.5. The protein is expressed in various cell types and is predominantly located in the cytoplasm, where it is involved in the delivery of proteins to the ER and the endoplasmic reticulum (ER-ESP system).

SEC24D functions as a protein transport protein by engaging with specific transport receptors, such as the protein kinase PDK4 (2) and the nucleotide transport protein, KCS2. These interactions allow Sec24D to facilitate the transport of various proteins, including heat shock proteins (HSPs), basket proteins (HOPs), and nucleotide transport proteins (NTPases).

In addition to its role in protein transport, SEC24D is also involved in the regulation of cellular processes, including cell division, DNA replication, and stress responses. Therefore, targeting SEC24D with small molecules or other therapeutic approaches may have potential implications for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Targeting Strategies for SEC24D

Several drug targeting strategies have been proposed for SEC24D, including:

1. Small-Molecule Inhibitors:

small molecules, such as inhibitors of Sec24D-interactive proteins, have been shown to be effective in inhibiting protein transport, either by binding directly to Sec24D or by modulating its interactions with other transport proteins. One example is the drug TI-212 , which is a small molecule inhibitor of the protein kinase PDK4, which is known to interact with SEC24D and enhance its transport function.

1. Monoclonal Antibodies:

Monoclonal antibodies (mAbs) targeting Sec24D have been developed as potential drug probes for various diseases. These antibodies are generated by clonal expansion of a single cell and can be directed against specific epitopes or domains within the protein. One example is the mAb against SEC24D, which has been shown to cross-react with various cell types and has been used to study its function in cell-to-cell protein transport.

1.RNA Interference:

RNA interference (RNAi) technology can be used to reduce the expression level of SEC24D, thereby inhibiting its function. RNAi screening has identified potential targets for SEC24D, including the N-terminal and C-terminal regions of the protein.

1. Overexpression of Modifying Proteins:

Overexpression of proteins involved in modifying Sec24D has been proposed as a potential strategy for studying its functions. For example, the overexpression of the protein involved in the N-terminal modification of Sec24D, N-trap, has been shown to enhance its transport function ( 12).

Conclusion

In conclusion, SEC24D is a protein transport protein that is highly conserved across different organisms and functions in the delivery of proteins to the ER and endoplasmic reticulum. Its potential as a drug target and biomarker for various diseases makes it an attractive target for small molecules, monoclonal antibodies, RNA interference, and overexpression strategies. Further research is needed to fully understand the mechanisms of SEC24D's function and its potential as a therapeutic agent.

Protein Name: SEC24 Homolog D, COPII Coat Complex Component

Functions: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:17499046, PubMed:20427317, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24C may have a different specificity compared to SEC24A and SEC24B (PubMed:17499046, PubMed:20427317, PubMed:18843296). May more specifically package GPI-anchored proteins through the cargo receptor TMED10 (PubMed:20427317). May also be specific for IxM motif-containing cargos like the SNAREs GOSR2 and STX5 (PubMed:18843296)

The "SEC24D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEC24D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets